Abstract:BACKGROUND:Cancer stem cells (CSCs) are responsible for cancer therapeutic resistance and metastasis. To date, in addition to surgery, chemotherapy, and radiotherapy, gene delivery has emerged as a potential therapeutic modality for ovarian cancer. Efficient and safe targeted gene delivery is complicated due to the tumor heterogeneity barrier. Ultrasound (US)-stimulated microbubbles (MBs) have demonstrated a method of enabling non-invasive targeted gene delivery. PURPOSE:The purpose of our study was to show the utility of poly(ethylene glycol)-SS-polyethylenimine-loaded microbubbles (PSP@MB) as an ultrasound theranostic and redox-responsive agent in a gene delivery system. PATIENTS AND METHODS:PSP nanoparticles were conjugated to the MB surface through biotin-avidin linkage, increasing the gene-loading efficiency of MB. The significant increase in the release of genes from the PSP@MB complexes was achieved upon ultrasound exposure. The positive surface charge in PSP@MB can condense the plasmid through electrostatic interactions; agarose-gel electrophoresis further confirmed the ability of PSP@MB to condense plasmids. The morphology, particle sizes and zeta potential of PSP@MB were characterized by transmission electron microscopy and dynamic light scattering. RESULTS:Laser confocal microscopy showed that the combination of ultrasound with PSP@MB could promote the cellular uptake of plasmids. Plasmids which encode enhanced green fluorescence protein (EGFP) reporter genes or luciferase reporter genes were delivered to CSCs in vitro and to subcutaneous xenografts in vivo via the combination of ultrasound with PSP@MB. Gene transfection efficiency was evaluated by fluorescence microscopy and In Vivo Imaging Systems. This study demonstrated that the combination of ultrasound with PSP@MB can remarkably promote gene delivery to solid tumors as well as diminishing the toxicity towards normal tissues in vivo. The combination of PSP@MB and the use of ultrasound can efficiently enhance accumulation, extravasation and penetration into solid tumors. CONCLUSION:Taken together, our study showed that this novel PSP@MB and ultrasound-mediated gene delivery system could efficiently target CSCs.

Targeted Delivery of Biodegradable Nanoparticles with Ultrasound-Targeted Microbubble Destruction-Mediated Hvegf-Sirna Transfection in Human PC-3 Cells in Vitro.

Echogenic PEGylated PEI-Loaded Microbubble As Efficient Gene Delivery System.

&Lt;p>echogenic PEGylated PEI-Loaded Microbubble As Efficient Gene Delivery System</p>

Polymeric vector-mediated delivery of an miR-21 inhibitor for prostate cancer treatment

Multifunctional Envelope-Type Sirna Delivery Nanoparticle Platform for Prostate Cancer Therapy.

Enhanced Delivery of PEAL Nanoparticles with Ultrasound Targeted Microbubble Destruction Mediated Sirna Transfection in Human MCF-7/S and MCF-7/ADR Cells in Vitro

Ultrasound-Induced Microbubble Cavitation Combined with Paclitaxel-Loaded Nanoparticles for the Elimination of PC-3 Cells in Vitro

Prostate Cancer Cell–specific VEGF Sirna Delivery System Using Cell Targeting Peptide Conjugated Polyplexes

Ultrasound Triggered Co‐Delivery of Therapeutic MicroRNAs and a Triple Suicide Gene Therapy Vector by Using Biocompatible Polymer Nanoparticles for Improved Cancer Therapy in Mouse Models

Ultrasound-responsive Microbubbles for Sonography-Guided Sirna Delivery.

Utilizing RNA nanotechnology to construct negatively charged and ultrasound-responsive nanodroplets for targeted delivery of siRNA

Targeted Delivery of Sirna-Generating DNA Nanocassettes Using Multifunctional Nanoparticles.

Biodegradable nanoparticles as siRNA carriers for: In vivo gene silencing and pancreatic cancer therapy

Tumor Microenvironment-Responsive Multistaged Nanoplatform for Systemic RNAi and Cancer Therapy.

Multi-functional Self-Assembled Nanoparticles for Pvegf-Shrna Loading and Anti-Tumor Targeted Therapy.

Ultrasound-mediated nanobubble destruction (UMND) facilitates the delivery of A10-3.2 aptamer targeted and siRNA-loaded cationic nanobubbles for therapy of prostate cancer

The Ph-Triggered Triblock Nanocarrier Enabled Highly Efficient Sirna Delivery for Cancer Therapy

Systemic delivery of therapeutic small interfering RNA using a pH-triggered amphiphilic poly-L-lysine nanocarrier to suppress prostate cancer growth in mice.

Tumor-targeted delivery of SNHG15 siRNA using a ZIF-8 nanoplatform: Towards a more effective prostate cancer therapy

Construction of a Targeting Nanoparticle of 3′,3″-Bis-peptide-sirna Conjugate/Mixed Lipid with Postinserted DSPE-PEG2000-cRGD

Functionally Modified Magnetic Nanoparticles for Effective Sirna Delivery to Prostate Cancer Cells in Vitro